Ally Financial After Q3: The Three Signals Worked — Tactical Long Opportunity

Hook & thesis

I said I'd watch three things for Ally: 1) whether management could steer originations toward higher-yielding auto and corporate loans, 2) whether credit metrics would remain stable as lower-yield mortgages ran off, and 3) whether excess capital would start flowing back to shareholders. Q3 results released on 10/20/2026 checked all three boxes.

Adjusted EPS of $1.34 (up 16% year-over-year) and revenue of roughly $2.29 billion (up about 5.6% YoY) show the company is generating profitable growth while preserving capital. Management raised the quarterly dividend to $0.35 and reported a CET1 ratio of 10.2%, leaving room for continued shareholder returns. Against a market cap of roughly $11.6 billion and a P/E below 9x, the risk/reward looks attractive from a valuation and execution standpoint. My trade: buy the pullback now with a mid-term horizon (45 trading days) and defined risk controls.

What Ally does and why the market should care

Ally Financial is a digital-focused finance company centered on automotive financing and related insurance products, with growing corporate finance operations. Its core segments are Automotive Finance Operations, Insurance Operations, Corporate Finance Operations, and Corporate & Other (treasury and ALM activities). The company processed 4.8 million auto applications in Q3 (up 20% YoY) and grew corporate finance loans about 40% YoY to $15.8 billion. That mix shift matters because higher-yielding auto and leveraged corporate loans expand net financing revenue and NIM, while the mortgage runoff reduces low-yield assets that were compressing margins.

Recent results and the three things I was watching

• Loan mix and originations: Auto application volume rose ~20% YoY to 4.8 million, and corporate finance loans jumped 40% YoY to $15.8 billion. That confirms the move into higher-yielding asset classes.
• Profitability and capital returns: Adjusted EPS was $1.34 in Q3 (up 16% YoY). Management increased the quarterly dividend to $0.35 and kept the CET1 ratio at a conservative 10.2%, supporting ongoing distributions.
• Credit profile: Management preserved credit metrics through the quarter even while increasing provisions in prior periods; the CET1 ratio and continued disciplined underwriting are consistent with a stable outlook on credit. Investors should still watch charge-off trends; the company did take higher provisions earlier in the year.

Valuation framing

At roughly $11.6 billion market cap and a current price around $37.99, Ally trades at a P/E near 8.7x (based on TTM EPS ~ $4.37). Price-to-book is about 0.75, and price-to-sales about 0.73. Enterprise value sits near $34.18 billion with EV/EBITDA around 24.8x and EV/sales about 2.15x. Free cash flow was reported at about $934 million (TTM), which supports dividends and potential buybacks.

In plain terms: earnings and cash flow support the current payout and leave room for valuation expansion if margins improve. A key valuation lever is net interest margin improvement as $18 billion of high-cost CDs roll off in 2026 and are replaced with lower-rate funding. If NIM normalizes higher and credit stays stable, a re-rating toward low-teens P/E or a lift toward book value would be reasonable.

Technical & market context

The stock recently corrected off a 52-week high of $47.29 (6/29/2026) and now trades below the 50-day SMA ($40.56). Short interest has ticked higher into late September (about 15.6M shares by 9/30 settlement) but days-to-cover remains modest (~4 days). RSI sits around 42.7 — not oversold but offering room for upside. The MACD shows bullish momentum building. In short, the technical backdrop is a pullback inside a longer bullish trend, which is a typical place to initiate a tactical long trade.

Trade plan (actionable)

Horizon: mid term (45 trading days) — enough time for quarter-to-quarter margin improvement and for the market to reprice shares on clearer forward guidance or early benefits from CD rolloffs.

Rationale: Entering at $37.99 puts you on the recent intraday price after Q3 confirmation of the three items I watched. A stop at $35.00 is just below the 52-week low area support (~$35.92) and limits downside if credit or funding stress re-emerges. Target of $45.00 assumes partial reversion to the June highs and a shift to low-double-digit valuations as NIM and EPS trajectory improve. This trade is intended to capture a mid-term re-rating; if the name breaks higher and confirms margin expansion, reduce the stop and consider upgrading to a position held into a longer horizon (180 trading days) with a higher target.

Catalysts (what to watch)

• Margin tailwinds from high-cost CD rolloffs and lower funding costs that should show in NIM over the next several quarters.
• Continued strength in auto originations and corporate finance growth — the company processed 4.8M auto applications in Q3 and corporate loans grew to $15.8B.
• Management commentary on capital return plans and buybacks following the dividend increase to $0.35 per quarter.
• Credit metrics and provisions — any sign of rising charge-offs or loan delinquency will change the thesis.
• Macro datapoints on consumer health and subprime delinquencies — auto and subprime trends affect loss rates and the valuation multiple the market assigns.

Risks and counterarguments

• Credit deterioration: If unemployment or consumer stress rises, auto and other consumer loan delinquencies could increase. Ally previously took a material provision ($430 million referenced in earlier commentary), and renewed or rising provisions would pressure EPS and multiple.
• Funding risk and deposit competition: The anticipated benefit from $18 billion of maturing high-yield CDs depends on Ally successfully replacing that funding at materially lower rates. If deposit competition keeps funding costs elevated, NIM upside will be muted.
• Macro slowdown in auto sales: A pullback in vehicle demand or a deterioration in used-car values could hurt originations and collateral values, pressuring earnings.
• Execution and underwriting risk in corporate finance: The corporate finance book grew 40% YoY to $15.8B. Rapid growth in leveraged lending can introduce concentration and underwriting risk if macro conditions deteriorate.
• Market sentiment and multiple compression: Even with stable fundamentals, banks can be repriced lower if the sector faces scare headlines or if interest-rate expectations shift unexpectedly.

Counterargument: Critics will point to rising short interest and recent insider selling as signs that the story is fully priced or that management might be trimming. Berkshire Hathaway's partial reduction in Ally in Q2 also raises eyebrows. These are valid flags: higher short interest increases volatility and insider selling can spook investors. That said, the Q3 data — EPS growth, originations, and a raised dividend with a CET1 of 10.2% — provide concrete operational reasons to stay constructive as long as credit does not materially worsen.

Conclusion and what would change my mind

Q3 validated the three items I flagged: a purposeful shift toward higher-yielding assets, intact capital metrics that enable shareholder returns, and operating leverage that supports faster EPS growth. At ~$37.99 and a sub-9x P/E, Ally looks attractive for a mid-term tactical long to capture a re-rating as NIM and EPS benefit from funding rolloffs and loan mix improvement.

I will change my view if one or more of the following happens: (1) materially higher charge-offs or a sustained rise in delinquencies, (2) NIM fails to improve once high-rate CDs mature, (3) management reduces capital returns or signals worse-than-expected underwriting performance, or (4) macro indicators point to a sharp drop in auto demand. Until then, the risk/reward supports a defined, mid-term long trade with the entry, stop, and target above.

Key metrics at a glance

If you take this trade, size it relative to a stop that limits downside to an amount you are comfortable with and monitor credit and funding headlines closely. The Q3 print gives a clear nod to the thesis — now it is a matter of execution and the macro backdrop.